Sanis Health Inc. Ranitidine recall in Canada: impurity risk
In plain language
This recall involves all lots of Sanis Health Inc. Ranitidine tablets (150mg and 300mg) sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Return the product as instructed by the official notice.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Impurity risk
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Impurity risk
What should consumers do?
Stop using the product immediately. Return the product as instructed by the official notice.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Impurity risk
When was this product recalled?
This product was recalled on September 24, 2019.
Is the Sanis Health Inc. brand affected by this recall?
Yes, Sanis Health Inc. products are affected by this recall. This recall involves all lots of Sanis Health Inc. Ranitidine tablets (150mg and 300mg) sold in Canada. It's being recalled because affected lots may contain an impurity called N-nitrosodimethylamine (NDMA). Stop using the product and follow the return steps in the official notice.